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Summary
Purpose: To compare the effectiveness of fine needle
aspiration cytology (FNAC) with core biopsy (CB) in the
pre-operative diagnosis of radial scar (RS) of the breast.
Patients and methods: A retrospective analysis was
made of all radial scars diagnosed on surgical histology
over an 8-year period.  Comparison was made between the
results of different preoperative needle biopsy techniques
and surgical histology findings.
Results:  Forty of 47 patients with a preoperative ra-
diological diagnosis of radial scar were included in this
analysis. Thirty-eight patients had impalpable lesions di-
agnosed on mammography and two presented with a pal-
pable lump. FNAC (n=17) was inadequate in 47% of pa-
tients, missed two co-existing carcinomas found in this group,
and gave a false positive or suspicious result for malignan-
cy in 4 patients. CB (n=23) suggested a RS in 15 patients,
but only diagnosed 4 out of 7 co-existing carcinomas found
in this group.
Conclusion:   CB is more accurate than FNAC in the
diagnosis of RS.  However, these data demonstrate that CB
may offer little to assist in the management of patients with
RS.  In summary, this paper advocates the use of CB in any
lesion with a radiological suspicion of carcinoma and di-
agnostic excision of all lesions thought to be typical of RS
on mammography.
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Introduction
Radial scars or complex sclerosing lesions are be-
nign lesions predominantly  detected by screening mam-
mography. They are usually surgically excised because
it is difficult to differentiate RS from small carcinomas
radiologically. In addition, a proportion of RS are associ-
ated with in situ or invasive carcinoma [1] and in these
patients further surgery is often necessary to achieve
complete tumour clearance and, in invasive disease, to
stage the axilla.
In the last 10 years image-guided core biopsy (CB)
has become an established part of breast diagnosis.
Although FNAC is still undertaken extensively, there is
increasing reliance on CB [2].  Published data show
advantages of sensitivity and specificity of CB over
FNAC [3].  CB also gives useful information regarding
tumour grade, hormone receptor status, and whether
invasive or in situ disease is present.  CB, however, is
associated with a small number of false negative and
very occasionally false positive results.
Current management advocates surgical excision
of all suspected RS to confirm the diagnosis and to de-
tect any associated premalignant or malignant change.
This paper evaluates the value of needle biopsy, and in
particular CB, in the diagnosis of RS.
Patients and methods
A retrospective review was performed on 47 cases
of RS diagnosed in our institution between 1991 and
1999.  This material includes 43 patients with mammo-
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graphic abnormalities detected within the National Health
Service Breast Screening Programme (NHSBSP) and
4 patients seen in the symptomatic clinic, 2 with palpable
lesions and 2 with incidental mammographic findings.
Patients with incidental microscopic RS on histology fol-
lowing routine excision biopsy for benign disease were
excluded from this study.  The results of preoperative
assessment by FNAC or CB were recorded. CB tech-
nique, including the method of image guidance, needle
gauge and the number of passes were noted.  The needle
biopsy results were compared with the final histology
following excision biopsy.  The contribution made by CB
to patient management was evaluated.
Results
Among the 47 patients reviewed (mean age of 54.5
years), 45 had impalpable lesions and two patients pre-
sented with a palpable lump. Five patients had no preop-
erative FNAC or CB and 2 patients declined surgery,
leaving 40 for further study. Seventeen of these patients
had FNAC and 23 patients had CB preoperatively.  The
mammographic appearances of the 40 lesions are out-
lined in Table 1.  The predominant feature was either a
spiculated mass or parenchymal deformity in 31 (77.5%)
of 40.  Four had mainly microcalcification and a mass
was present in 3 patients.  In two patients who present-
ed with a palpable mass, the mammogram was normal
but both lesions were visible on ultrasound (US).
The final histology showed a benign RS with no
atypia or malignancy in 28/40 (70%) patients. The fol-
lowing pathological features were associated in the re-
mainder: invasive ductal carcinoma (n=2, 5%), ductal
carcinoma in situ (DCIS) (n=4, 10%), lobular carcinoma
in situ (LCIS) (n=3, 7.5%) and atypical ductal hyper-
plasia (ADH) (n=3, 7.5%). The results are summarised
in Table 2.
In the FNAC group (n=17) 8 (47%) were inad-
equate (C1, category), 4 were benign (C2, 23%), one
was suspicious probably benign (C3, 6%), 3 were suspi-
cious probably malignant (C4, 18%) and one was malig-
nant (C5, 6%). On final histology there was one inva-
sive carcinoma in this group (FNAC - C1) and one DCIS
(FNAC - C2). Among 4 patients in whom the FNAC
was reported as C4 or C5, 3 had benign RS without
atypia and one had associated ADH.
In the CB group (n=23) 18 (78%) were reported
as benign with no atypia, one (4%) had ADH, one (4%)
had LCIS and 3 (13%) had DCIS. Core biopsy sug-
gested RS as the likely diagnosis in 15 out of 23 patients
(65%). On final histology 13 of 18 (72%) benign cores
proved to be RS without atypia or malignancy; the other
5 patients had ADH (n=2, 11%), LCIS (n=1, 5.5%), DCIS
(n=1, 5.5%) and invasive cancer (n=1, 5.5%). CB was
accurate in 2 of 3 patients with DCIS. In one patient the
core suggested DCIS but the final diagnosis was LCIS.
The method of biopsy for FNAC is displayed in
Table 3a.  A more detailed analysis of the method of CB
is shown in Table 3b. Nine (39%) of the lesions could be
seen using US and this was the preferred method of
CB.  For lesions that could not be seen on US or where
US was not performed, stereotactic – n  = 12 (52%) –
Table 1. Dominant mammographic appearances of radial scars
(n=40)
Mammographic appearances Number of patients (%)
Spiculated mass 16 (40)
Parenchymal deformity 15 (37.5)
Microcalcification 4 (10)
Mass 3 (7.5)
Normal* 2 (5.0)
*both presented with breast lumps that were mammographically
occult but demonstrated on ultrasound
Table 2. Correlation between needle biopsy and surgical histology results
Final histology* FNAC (n=17) Core Biopsy (n=23)
C1 C2 C3 C4 C5 Inadequate benign ADH LCIS DCIS IC
Benign RS 7 3 1 2 1 – 13 1 – – –
RS with ADH – – – 1 – – 2 – – – –
RS with LCIS – – – – – – 1 – 1 1 –
RS with DCIS – 1 – – – – 1 – – 2 –
RS with IC 1 – – – – – 1 – – – –
FNAC: fine needle aspiration cytology; RS: radial scar; ADH: atypical ductal hyperplasia; LCIS: lobular carcinoma in
situ; DCIS: ductal carcinoma in situ; IC: invasive carcinoma
*In the case of several pathological conditions being associated with the RS, only the worst prognosis lesion was
considered; e.g., a lesion containing both DCIS and LCIS is presented as DCIS
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or alphanumeric plate – n = 2 (9%) – was used.  The
majority (89%) of US-guided biopsies were performed
using 16 gauge needles, with a mean of 2.6 passes per
procedure.  Larger gauge needles with more frequent
passes tended to be used for stereotactic-guided biop-
sies.  In 75% of biopsies 14 gauge needles were used,
with an overall average of 7.9 passes.  There was com-
plete correlation between the CB results and the final
surgical histology in 9 of 12 (75%) of stereotactic-guided
biopsies and in 6 of 9 (67%) of US-guided biopsies.
Discussion
These results suggest that FNAC has limited value
in the preoperative assessment of RS in keeping with
two previous studies [1,4]. The high inadequate rate (C1,
47% in this study) confirms an earlier study [5], and is
partly due to the fibrous nature of the lesion [6].  Fur-
thermore, FNAC often misses associated carcinoma [1,5]
and both cancers in the FNAC group in this study (one
invasive and one DCIS) scored C1 and C2, respectively.
Of potentially greater clinical hazard is the single false
positive FNAC (C5) with benign RS, which might have
resulted in inappropriate cancer surgery.  Such false
positive FNAC results have previously been described
in patients with RS [1,6,7].
This study clearly demonstrates that CB is supe-
rior to FNAC in the diagnosis of RS.  We have therefore
evaluated the extent to which CB affects the manage-
ment of patients with RS. In this series there were 2
patients who had associated DCIS diagnosed preopera-
tively.  These patients were able to undergo adequate
wide local excision of their malignancy at a single op-
eration rather than undergoing an initial diagnostic surgi-
cal excision.  The disadvantages of performing CB in all
patients include the time, effort, expense and patient dis-
comfort when attempting to biopsy lesions that are fre-
quently challenging to image.   In addition there was one
false positive CB diagnosis of DCIS in this series that
was downgraded to LCIS on subsequent surgical exci-
sion. There were 2 cases of associated malignancy where
the CB diagnosed benign RS only.  Both these patients
required second operations for definitive cancer treat-
ment.
An alternative strategy is to consider surgical ex-
cision of all RS diagnosed on imaging without a preop-
erative needle biopsy.   In our series potentially 23 un-
necessary needle biopsies with their attendant discom-
fort and expense would have been avoided.  One false
positive patient diagnosed as having DCIS on needle bi-
opsy would have undergone excision biopsy rather than
wide excision. False positive results with CB are exceed-
ingly uncommon.  There has been one additional false
positive case reported under similar circumstances where
a CB diagnosis of tubular carcinoma was found to be
due to benign RS following surgery [8].  Four patients in
our series would have required additional therapeutic
surgery (3 DCIS, 1 invasive carcinoma). Two of these
additional operations would have been avoided by the
preoperative core biopsies diagnosing their associated
DCIS.
Therefore, in this series of 23 patients undergoing
core biopsy, if all presumed RS underwent surgical exci-
sion without previous biopsy, a total of 27 operations
would be necessary, 4 patients with malignancy having
to undergo subsequent cancer surgery.  This is compa-
rable to 25 operations required for all patients if each
had preoperative core biopsies as is the case in our insti-
tution.  These 2 additional operations need to be offset
against the expense and time to perform the 23 core
biopsies and the potentially unnecessary surgery that the
patient with an erroneous DCIS diagnosis may have
undergone.
Although CB substantially outperforms FNAC in
diagnosing RS, it actually contributes little in changing
the management of patients with this condition. The main
problem relates to distinguishing RS from carcinoma on
radiological grounds only.  If carcinoma is thought to be
a distinct possibility following mammography, then core
biopsy should be performed, as this will reduce unnec-
essary second operations.  As a result, CB will be per-
formed in a proportion of patients with RS.
Table 3. Methods of biopsy
3a.  FNAC (n=17)
Method of biopsy n (%)
Ultrasound 8 (47.1)
Alphanumeric plate 5 (29.5)
Stereotactic 3 (17.6)
Palpation 1 (5.8)
3b.  Core biopsy (n=23)
Method of n (%) Gauge Number Complete
biopsy of passes histological
correlation*
n (%)
14G 16G 18G Mean (range)
Stereotactic 12 (52) 9 1 2 7.9 (6-10) 9 (75)
Ultrasound 9 (39) 1 8 0 2.6 (1-5) 6 (67)
Alphanumeric 2  (9) 2 - - 5.0 (4-6) 1 (50)
plate
*complete correlation between the core biopsy and final histology
results
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Is there any way therefore to maximize the infor-
mation obtained from the needle biopsy?  In our series
there was a trend to more accurate needle biopsy/surgi-
cal histology correlation when a greater volume of tis-
sue (larger gauge needles and more passes) was re-
moved.  This would concur with the findings of a previ-
ous study that demonstrates a closer correlation between
needle biopsy and subsequent surgical specimens when
vacuum-assisted biopsies (VAB) are used [9].  This is
further illustrated by reduced upgrading following a VAB
diagnosis of benign conditions, such as atypical ductal
hyperplasia, to DCIS when compared with CB [9-11].
If all suspected RS underwent VAB, with a presumed
increase in the diagnosis of associated malignancy, the
number of additional operations may be reduced.  This
would, however, have to be offset against the consider-
able additional expense of VAB over CB.
In summary, we would advocate the use of CB in
any lesion with a radiological suspicion of carcinoma.
Our data show that CB may offer little to alter the man-
agement of patients with RS. It is unreliable at detecting
associated malignancy and so will reduce some, but not
all, of the need for additional cancer surgery.  If RS is
suspected then the greater the volume of tissue removed
the more reliably should associated malignancy be de-
tected.
At present therefore we would advocate diagnos-
tic excision of all lesions thought to be typical of RS on
mammography.  If mammography is suspicious of ma-
lignancy CB should be performed.  This strategy may
be more cost-effective whilst we await the accrual of
more data on the efficacy of VAB in the diagnosis of
RS.
References
1. Mokbel K, Price RK, Mostafa A et al.  Radial scar and carci-
noma of the breast: microscopic findings in 32 cases.  The
Breast 1999; 8: 339-342.
2. Britton PD, Flower CDR, Freeman AH et al. Changing to core
biopsy in an NHS breast screening unit. Clin Radiol 1997; 52:
764-776.
3. Britton PD.  Fine needle aspiration or core biopsy.  The Breast
1999; 8: 1-4.
4. Greenberg ML, Camaris C, Psarianos T, Ung OA, Lee WB. Is
there a role for fine-needle aspiration in radial scar/complex
sclerosing lesions of the breast? Diagn Cytopathol 1997; 16:
537-542.
5. Douglas-Jones AG, Pace DP. Pathology of R4 spiculated le-
sions in the breast screening programme. Histopathology 1997;
30: 214-220.
6. de la Torre M, Lindholm K, Lindgren A. Fine needle aspira-
tion cytology of tubular carcinoma and radial scar. Acta Cytol
1994; 38: 884-890
7. Lamb J, McGoogan E. Fine needle aspiration cytology of
breast in invasive carcinoma of tubular type and in radial scar/
complex sclerosing lesions. Cytopathology 1994; 5: 17-26.
8. Britton PD, McCann J.  Needle biopsy in the NHS Breast
Screening Programme 1996/97: how much and how accurate?
The Breast 1999; 8: 5-11.
9. Darling ML, Smith DN, Lester SC et al.  Atypical ductal
hyperplasia and ductal carcinoma in situ as revealed by large-
core needle breast biopsy: results of surgical excision. Am J
Roentgenol 2000; 175: 1341-1346.
10. Burbank F. Stereotactic breast biopsy of atypical ductal hy-
perplasia and ductal carcinoma in situ lesions: improved accu-
racy with directional, vacuum-assisted biopsy.  Radiology,
1997; 202: 843-847.
11. Jackman RJ, Burbank F, Parker SH et al. Atypical ductal
hyperplasia diagnosed at stereotactic breast biopsy: improved
reliability with 14-gauge, directional, vacuum-assisted biopsy.
Radiology 1997; 204: 485-488.
